semaglutide for kidney disease in patients with overweight or obesity and chronic without diabetes: a randomized double-blind placebo-controlled clinical trial Obesity drugs could slow the

This is why more people are shifting towards glutathione tablets for skin whitening

GLP-1 receptor agonists are well known to cause gastrointestinal symptoms, including abdominal pain, diarrhea, and vomiting

At the six-month mark, I was down 52 pounds total, landing at 146 pounds

85 DNA damage-regulated autophagy modulator 1 (DRAM1) is essential for inducing autophagy and apoptosis and is highly expressed in UC patients

Data sources: County-level adult obesity prevalence estimates from CDC PLACES (most recent release) and Texas DSHS BRFSS

Predicting the global potential distribution of Bursaphelenchus xylophilus using an ecological niche model: Expansion trend and the main driving factors